Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
no injectable protocol has been validated in controlled human trials
The GHK-Cu fraction is now twice the upper therapeutic threshold (2 mg/day)
Here's why the combination works better than either one alone
It activates several overlapping pathways, notably VEGFR2 and nitric oxide synthesis via the Akt-eNOS axis, promoting angiogenesis, fibroblast activity, and neuromuscular stabilization
US$ 28.44
US$ 29.60
US$ 23.95
